# OnCo record nct05059522 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05059522/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05059522", "NCT05059522" ;
  schema:name "Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing"@en ;
  schema:description "A phase 3 trial of Avelumab, Talazoparib, Pemetrexed in ovarian cancer, run by Pfizer, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05059522/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05059522> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2021-09-29" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/avelumab/>, <https://onco.cc/drugs/talazoparib/>, <https://onco.cc/drugs/pemetrexed/>, <https://onco.cc/drugs/axitinib/>, <https://onco.cc/drugs/utomilumab/> ;
  onco:companies <https://onco.cc/companies/pfizer/> .